ATE233320T1 - Antagonisten von humanem interleukin-6, welche zur bindung mit gp 130 unfähig sind und ihre verwendung in der herstellung von pharmazeutische zusammensetzungen - Google Patents
Antagonisten von humanem interleukin-6, welche zur bindung mit gp 130 unfähig sind und ihre verwendung in der herstellung von pharmazeutische zusammensetzungenInfo
- Publication number
- ATE233320T1 ATE233320T1 AT96912205T AT96912205T ATE233320T1 AT E233320 T1 ATE233320 T1 AT E233320T1 AT 96912205 T AT96912205 T AT 96912205T AT 96912205 T AT96912205 T AT 96912205T AT E233320 T1 ATE233320 T1 AT E233320T1
- Authority
- AT
- Austria
- Prior art keywords
- human interleukin
- binding
- pct
- antagonists
- inapable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95RM000273A IT1276555B1 (it) | 1995-04-28 | 1995-04-28 | Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni |
PCT/IT1996/000084 WO1996034104A1 (en) | 1995-04-28 | 1996-04-26 | Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE233320T1 true ATE233320T1 (de) | 2003-03-15 |
Family
ID=11403338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96912205T ATE233320T1 (de) | 1995-04-28 | 1996-04-26 | Antagonisten von humanem interleukin-6, welche zur bindung mit gp 130 unfähig sind und ihre verwendung in der herstellung von pharmazeutische zusammensetzungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US5972902A (de) |
EP (1) | EP0822986B1 (de) |
JP (2) | JP3373856B2 (de) |
AT (1) | ATE233320T1 (de) |
CA (1) | CA2218372C (de) |
DE (1) | DE69626387T2 (de) |
DK (1) | DK0822986T3 (de) |
ES (1) | ES2191096T3 (de) |
IT (1) | IT1276555B1 (de) |
PT (1) | PT822986E (de) |
WO (1) | WO1996034104A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017441A1 (fr) * | 1995-11-07 | 1997-05-15 | Kaneka Corporation | Autoantigenes |
DE19704979A1 (de) * | 1996-02-07 | 1997-08-14 | Max Delbrueck Centrum | Retroviraler Vektor für den Gentransfer eines IL6-Antagonisten in humane hämatopoetische Stammzellen |
ES2312184T3 (es) | 1997-03-21 | 2009-02-16 | Chugai Seiyaku Kabushiki Kaisha | Agentes preventivos terapeuticos para el tratamiento de esclerosis multiple, que contienen anticuerpos anti-receptores de il-6 antagonistas. |
IT1291932B1 (it) * | 1997-06-20 | 1999-01-21 | Angeletti P Ist Richerche Bio | Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma |
ES2241583T3 (es) | 2000-03-06 | 2005-11-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Uso de antagonistas de interleuquina 6 para el tratamiento de tumores dependientes de estrogenos. |
IL161968A0 (en) * | 2001-11-14 | 2005-11-20 | Centocor Inc | Anti-il-6 antibodies, compositions, methods and uses |
US20050100550A1 (en) * | 2003-11-10 | 2005-05-12 | Mohit Trikha | Anti-angiogenic uses of IL-6 antagonists |
ITRM20050103A1 (it) * | 2005-03-10 | 2006-09-11 | Rocco Savino | Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi. |
PA8672101A1 (es) | 2005-04-29 | 2006-12-07 | Centocor Inc | Anticuerpos anti-il-6, composiciones, métodos y usos |
US8188235B2 (en) | 2008-06-18 | 2012-05-29 | Pfizer Inc. | Antibodies to IL-6 and their uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994009138A1 (en) * | 1992-10-20 | 1994-04-28 | Cetus Oncology Corporation | Interleukin-6 receptor antagonists |
IT1261787B (it) * | 1993-06-23 | 1996-06-03 | Angeletti P Ist Richerche Bio | Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. |
-
1995
- 1995-04-28 IT IT95RM000273A patent/IT1276555B1/it active IP Right Grant
-
1996
- 1996-04-26 ES ES96912205T patent/ES2191096T3/es not_active Expired - Lifetime
- 1996-04-26 WO PCT/IT1996/000084 patent/WO1996034104A1/en active IP Right Grant
- 1996-04-26 DE DE69626387T patent/DE69626387T2/de not_active Expired - Fee Related
- 1996-04-26 CA CA002218372A patent/CA2218372C/en not_active Expired - Fee Related
- 1996-04-26 JP JP53233396A patent/JP3373856B2/ja not_active Expired - Fee Related
- 1996-04-26 DK DK96912205T patent/DK0822986T3/da active
- 1996-04-26 PT PT96912205T patent/PT822986E/pt unknown
- 1996-04-26 AT AT96912205T patent/ATE233320T1/de not_active IP Right Cessation
- 1996-04-26 US US08/945,529 patent/US5972902A/en not_active Expired - Fee Related
- 1996-04-26 EP EP96912205A patent/EP0822986B1/de not_active Expired - Lifetime
-
2002
- 2002-09-05 JP JP2002259481A patent/JP2003153691A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT822986E (pt) | 2003-07-31 |
CA2218372A1 (en) | 1996-10-31 |
IT1276555B1 (it) | 1997-11-03 |
JPH10506538A (ja) | 1998-06-30 |
DE69626387D1 (de) | 2003-04-03 |
DE69626387T2 (de) | 2003-12-11 |
EP0822986A1 (de) | 1998-02-11 |
ITRM950273A1 (it) | 1996-10-28 |
CA2218372C (en) | 2001-07-31 |
JP2003153691A (ja) | 2003-05-27 |
DK0822986T3 (da) | 2003-04-28 |
EP0822986B1 (de) | 2003-02-26 |
US5972902A (en) | 1999-10-26 |
ES2191096T3 (es) | 2003-09-01 |
JP3373856B2 (ja) | 2003-02-04 |
ITRM950273A0 (it) | 1995-04-28 |
WO1996034104A1 (en) | 1996-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI963101A0 (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
CY1114919T1 (el) | Anti-mag ανθρωποποιημενα αντισωματα και οι χρησεις τους για την αντιμετωπιση του εγκεφαλικου επεισοδιου | |
ATE173468T3 (de) | Substituierte dihydrobenzo(b,f)azepine, verfahren zu ihrer herstellung, ihre verwendung zur behandlung von erkrankungen des zentralnervensystems und sie enthaltende pharmazeutische zusammensetzungen | |
DE69830404D1 (de) | P38-inhibitoren | |
ATE450508T1 (de) | Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren | |
TR199900318T2 (xx) | IL-8 resept�r antagonistleri. | |
DK1053256T3 (da) | Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf | |
ATE233320T1 (de) | Antagonisten von humanem interleukin-6, welche zur bindung mit gp 130 unfähig sind und ihre verwendung in der herstellung von pharmazeutische zusammensetzungen | |
DE69228997D1 (de) | Menschliche il-3-varianten | |
MXPA01006006A (es) | Cadena receptora de citocina. | |
BR0208357A (pt) | Composto, composição farmacêutica, método de antagonização de um receptor de fator de liberação de corticotropina (crf), método de tratamento de disfunção, método de triagem de ligantes, método de detecção de receptores de crf, método de inibição da ligação de crf, artigo industrializado e usos do composto | |
BG108427A (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diaryl pyrimidines as crf1 receptor modulators | |
PT628033E (pt) | Derivados de benzodiazepina uteis como antagonistas dos receptores-cck | |
DE69811248D1 (de) | Verwendung eines 5ht2 rezeptor-antagonisten zur behandlung von schlafapnoe | |
GB9814892D0 (en) | Treatment of celiac disease | |
ATE474047T1 (de) | Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen | |
HUP0100611A2 (hu) | Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére | |
DE69809284D1 (de) | Immunomodulator mit anti-mikrobakteriellen und anti-mykobakteriellen eigenschaften, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen zur behandlung von mykobakteriosen sowie von chronischen und nicht-spezifischen lungenzuständen, sexuell übertragbaren krankheiten und den daraus resultierenden immunschwächen | |
GR880100084A (el) | Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν | |
BG101849A (en) | Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions | |
BG104022A (en) | New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists | |
HUP0100105A2 (hu) | TNF-antagonisták alkalmazása szeptikus betegségek kezelésére szolgáló gyógyszerként | |
DE59607683D1 (de) | Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
DE60004473D1 (de) | Verwendung von gaba-b rezeptor liganden zur herstellungen von medikamenten zur behandlung von neurodegenerativen erkrankungen | |
EP0480391A3 (en) | Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0822986 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |